Samsung and Biogen win first EU approval for an Enbrel copycat

Damian Garde

A joint venture between and South Korean giant won Europe's for a lower-cost version of Amgen and Pfizer's blockbuster , planning to launch its injection in the coming weeks.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS